source
- Sun Pharma’s $12 billion Organon deal signals global push but India still faces R&D hurdlesSun Pharma is close to completing a nearly $12 billion purchase of Organon, which would lift the Indian group into the world’s top‑25 pharmaceutical companies and expand its footprint to about 150…
- FDA approves adjuvant atezolizumab for MRD-positive muscle-invasive bladder cancer, says Dr. HafronThe U.S. Food and Drug Administration has granted approval for adjuvant atezolizumab in patients with MRD-positive muscle-invasive bladder cancer. The decision expands the use of the immunotherapy…